Investor Presentaiton

Highly Accretive Transaction 2021 guidance; $ millions Revenue Organic Revenue Growth Adj. EBITDA Adj. EBITDA Margin ++ adapthealth adapthealth (1) ARRAeroCare® $1,300 to $1,400 $2,050 to $2,200 7% to 10% 8% to 10% $260 to $280 $480 to $515 20% Adj. EBITDA - PC $180 to $200 23% $300 to $330 Adj. EBITDA - PC Margin 14% 15% AdaptHealth's acquisition of AeroCare will create shareholder value through significant and immediate accretion to growth, earnings and cash flows ++ adapthealth Note: PC Patient Capex (1) Guidance assumes 11 months of AeroCare ownership (i.e., closing on 1/31/2021). Approximately $25 million of cost synergies expected to be realized in 2021. 5 LO

View entire presentation